el Amrani R, Cornier E, Henry-Suchet J, Sarjdine K, Mayenga J M, Loysel T, Belaish-Allart J
Service de gynécologie-obstétrique et reproduction humaine, hôpital Jean-Rostand, 141, Grande Rue, 92311 Sevres, France.
Gynecol Obstet Fertil. 2001 Feb;29(2):116-22. doi: 10.1016/s1297-9589(00)00061-8.
Compare two medical strategies associated to surgery in women requiring for chronic pelvic pain due to stage III-IV endometriosis.
Two different patient groups, A (N 27) and B (N 41), requiring for chronic pelvic pain, associated with AFS stage III-IV endometriosis, operated on from 1992 to 1997, were compared. The medium age was 35 and 34 years, respectively. Pelvic pain, classified in three stages, was similar in both groups but they were more AFS stage IV in group A, 67% than in group B, 46% (p < 0.01). Both groups had similar operative procedure: laparoscopic resection of deep endometriotic nodules or endometriomas, plus destruction of small superficial lesions using CO2 laser (A) or bipolar coagulation (B). Associated medical strategy was different: group A: operative laparoscopy without preoperative treatment and in 25% a second laparoscopy taking place after two-three months of LHRH analogues; no postoperative treatment; group B, operative laparoscopy taking place after ovarian blockage with three-six weeks of Diane (Androcur + ethinyl estradiol), then two-three months of analogue postoperative treatment immediately followed by long term progestoid treatment in order to prevent recurrences in women without pregnancy desire.
After one year, 6/27 (22%) of A and 3/41 (7%) of B had no follow-up. Of the followed patients, a complete improvement was observed in 18/21 (86%) A, 33/38 (87%) B, moderate pelvic pain continued in 2/21 (10%) A, 4/38 (11%) B, and the treatment was in failure in 1/21 (5%) A, 1/38 (3%) B, without significant difference. After two years, 67% of A and 76% of B had a follow-up and the corresponding rates of complete improvement are 72% (A), 87% (B), incomplete improvement: 22% (A), 10% (B) and failure: 6% (A), 3% (B). The difference is lightly significant (p < 0.05) and remains so if patients without follow-up are considered as failures. There was no persistence nor recurrence of endometriosis nor endometrioma two years after the surgery was completed.
Since there were more stage IV endometriosis in group A than in B, the different medical strategies and particularly the long term postoperative treatment used in B seem have little influence on results. However, these data was obtained in women of medium age > 30, with a relatively short follow-up. It should be of interest to compare in a prospective multicentric study the long term follow-up of two cohorts of young women operated on for stage III-IV endometriosis, receiving or not a long term medical treatment after surgery in order to prevent recurrences.
比较两种与手术相关的医疗策略,用于治疗因III-IV期子宫内膜异位症导致慢性盆腔疼痛的女性患者。
比较了1992年至1997年期间接受手术的两组不同患者,A组(N = 27)和B组(N = 41),她们均因AFS III-IV期子宫内膜异位症伴有慢性盆腔疼痛。两组患者的平均年龄分别为35岁和34岁。盆腔疼痛分为三个阶段,两组相似,但A组AFS IV期患者比例更高,为67%,而B组为46%(p < 0.01)。两组手术方式相似:腹腔镜切除深部子宫内膜异位结节或子宫内膜瘤,再用二氧化碳激光(A组)或双极电凝(B组)破坏浅表小病灶。相关医疗策略不同:A组:术前不进行治疗,直接行手术腹腔镜检查,25%的患者在使用促性腺激素释放激素(LHRH)类似物两至三个月后进行第二次腹腔镜检查;术后不进行治疗;B组:在使用炔诺酮(安宫黄体酮+炔雌醇)进行卵巢阻断三至六周后行手术腹腔镜检查,术后立即进行两至三个月的类似物治疗,随后对无妊娠意愿的女性进行长期孕激素治疗以预防复发。
一年后,A组27例中有6例(22%)、B组41例中有3例(7%)失访。在随访的患者中,A组21例中有18例(86%)完全改善,B组38例中有33例(87%)完全改善;A组21例中有2例(10%)、B组38例中有4例(11%)仍有中度盆腔疼痛;A组21例中有1例(5%)、B组38例中有1例(3%)治疗失败,差异无统计学意义。两年后,A组67%、B组76%的患者接受了随访,完全改善率分别为72%(A组)、87%(B组),改善不完全率分别为22%(A组)、10%(B组),失败率分别为6%(A组)、3%(B组)。差异有轻度统计学意义(p < 0.05),若将失访患者视为治疗失败,则差异仍然存在。手术完成两年后,未发现子宫内膜异位症或子宫内膜瘤持续存在或复发。
由于A组IV期子宫内膜异位症患者多于B组,不同的医疗策略,特别是B组采用的长期术后治疗,似乎对结果影响不大。然而,这些数据是在平均年龄大于30岁的女性中获得的,随访时间相对较短。在一项前瞻性多中心研究中比较两组因III-IV期子宫内膜异位症接受手术的年轻女性患者的长期随访情况,一组术后接受长期药物治疗以预防复发,另一组不接受,这可能会很有意义。